ATE216229T1 - Emulsion zur verabreichung eines sphingolipids und deren verwendung - Google Patents

Emulsion zur verabreichung eines sphingolipids und deren verwendung

Info

Publication number: ATE216229T1
Authority: AT; Austria
Prior art keywords: emulsion; sphingolipid; administration; cholesterol; cationic
Prior art date: 1994-12-07

Application number

AT95942970T

Other languages

English (en)

Inventor

Robert T Lyons

Original Assignee

Pharmacia & Upjohn Ab

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-07

Filing date

1995-12-01

Publication date

2002-05-15

1995-12-01 Application filed by Pharmacia & Upjohn Ab, Lilly Co Eli filed Critical Pharmacia & Upjohn Ab

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216229T1 publication Critical patent/ATE216229T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT95942970T 1994-12-07 1995-12-01 Emulsion zur verabreichung eines sphingolipids und deren verwendung ATE216229T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/351,635 US5635536A (en)	1994-12-07	1994-12-07	Emulsion suitable for administering a sphingolipid
PCT/US1995/015687 WO1996017603A1 (en)	1994-12-07	1995-12-01	Emulsion suitable for administering a sphingolipid and use thereof

Publications (1)

Publication Number	Publication Date
ATE216229T1 true ATE216229T1 (de)	2002-05-15

Family

ID=23381694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95942970T ATE216229T1 (de)	1994-12-07	1995-12-01	Emulsion zur verabreichung eines sphingolipids und deren verwendung

Country Status (10)

Country	Link
US (2)	US5635536A (de)
EP (1)	EP0799035B1 (de)
JP (1)	JPH10510267A (de)
AT (1)	ATE216229T1 (de)
AU (1)	AU4414096A (de)
DE (1)	DE69526450T2 (de)
DK (1)	DK0799035T3 (de)
ES (1)	ES2177676T3 (de)
PT (1)	PT799035E (de)
WO (1)	WO1996017603A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6720184B1 (en)	1991-08-05	2004-04-13	Emory University	Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination
AU692255B2 (en) *	1995-04-24	1998-06-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Self-emulsifiable formulation producing an oil-in-water emulsion
US6982142B2 (en) *	1997-12-01	2006-01-03	John Wayne Cancer Institute	Methods for screening therapeutically effective agents
WO1999041266A1 (en)	1998-02-12	1999-08-19	Emory University	Sphingolipid derivatives and their methods of use
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
US6194391B1 (en)	1998-06-24	2001-02-27	Emory University	3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol
US6352844B1 (en)	1998-06-29	2002-03-05	Childrens Hospital Los Angeles	Treatment of hyperproliferative disorders
US6368831B1 (en)	1998-06-29	2002-04-09	Childrens Hospital Los Angeles	Treatment of hyperproliferative disorders
WO2000010531A1 (en)	1998-08-19	2000-03-02	Rtp Pharma Inc.	Injectable aqueous dispersions of propofol
GB2359747B (en) *	2000-02-29	2002-04-24	Maelor Pharmaceuticals Ltd	Anaesthetic formulations
US7846969B2 (en) *	2001-12-10	2010-12-07	Kao Corporation	Ceramide emulsions
ATE331507T1 (de) *	2003-02-21	2006-07-15	Los Angeles Childrens Hospital	Stabile pharmazeutische zusammensetzung mit safingol und verfahren zu dessen verwendung
JP2006028109A (ja) *	2004-07-20	2006-02-02	Kao Corp	水中油型乳化組成物
US8557861B2 (en)	2004-09-28	2013-10-15	Mast Therapeutics, Inc.	Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2011044207A2 (en) *	2009-10-06	2011-04-14	L'oreal S.A.	Compositions containing a high concentration of polar sphingolipid(s)
JP6960984B2 (ja) *	2019-12-26	2021-11-05	三菱電機株式会社	電子装置及びその絶縁部材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1792410B2 (de) *	1967-09-01	1980-03-13	Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm	Arzneimittelzubereitung zur intravenösen Injektion
JPS6030652B2 (ja) *	1979-05-07	1985-07-17	株式会社ミドリ十字	静脈注射用脂肪乳剤
IT1171432B (it) *	1981-08-03	1987-06-10	Fidia Farmaceutici	Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4937232A (en) *	1986-09-15	1990-06-26	Duke University	Inhibition of protein kinase C by long-chain bases
US4816450A (en) *	1986-09-15	1989-03-28	Duke University	Inhibition of protein kinase C by long-chain bases
CA2013755C (en) *	1989-04-05	1993-11-30	Simon Benita	Medicinal emulsions
US5364632A (en) *	1989-04-05	1994-11-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Medicinal emulsions
US5198470A (en) *	1989-09-21	1993-03-30	L'oreal	Lipid compounds derived from sphingosines, process for preparing these and their applications, in particular in cosmetics and in the pharmacy of skin conditions
FR2652002B1 (fr) *	1989-09-21	1991-11-29	Oreal	Nouveaux composes lipidiques derives des sphingosines, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie.
DE4015108A1 (de) *	1990-05-11	1991-11-14	Leopold Pharma Gmbh	Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe
US5149794A (en) *	1990-11-01	1992-09-22	State Of Oregon	Covalent lipid-drug conjugates for drug targeting
USH1168H (en) *	1991-08-21	1993-04-06	The United States Of America As Represented By The Secretary Of The Navy	Inhibitors of protein kinase C activity as protectors against septic shock and reducers of ARDS

1994
- 1994-12-07 US US08/351,635 patent/US5635536A/en not_active Expired - Fee Related
1995
- 1995-12-01 WO PCT/US1995/015687 patent/WO1996017603A1/en active IP Right Grant
- 1995-12-01 PT PT95942970T patent/PT799035E/pt unknown
- 1995-12-01 DE DE69526450T patent/DE69526450T2/de not_active Expired - Fee Related
- 1995-12-01 AU AU44140/96A patent/AU4414096A/en not_active Abandoned
- 1995-12-01 JP JP8517678A patent/JPH10510267A/ja not_active Ceased
- 1995-12-01 DK DK95942970T patent/DK0799035T3/da active
- 1995-12-01 AT AT95942970T patent/ATE216229T1/de not_active IP Right Cessation
- 1995-12-01 EP EP95942970A patent/EP0799035B1/de not_active Expired - Lifetime
- 1995-12-01 ES ES95942970T patent/ES2177676T3/es not_active Expired - Lifetime
1996
- 1996-07-16 US US08/680,993 patent/US5677341A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0799035A4 (de)	1999-06-09
DK0799035T3 (da)	2002-07-22
EP0799035B1 (de)	2002-04-17
EP0799035A1 (de)	1997-10-08
PT799035E (pt)	2002-09-30
US5677341A (en)	1997-10-14
ES2177676T3 (es)	2002-12-16
US5635536A (en)	1997-06-03
AU4414096A (en)	1996-06-26
WO1996017603A1 (en)	1996-06-13
DE69526450D1 (de)	2002-05-23
DE69526450T2 (de)	2002-11-14
JPH10510267A (ja)	1998-10-06

Similar Documents

Publication	Publication Date	Title
ATE216229T1 (de)	2002-05-15	Emulsion zur verabreichung eines sphingolipids und deren verwendung
ATE149828T1 (de)	1997-03-15	Arzneistofformulierung zur parenteralen anwendung
PT92131A (pt)	1990-04-30	Processo para a preparacao de meios para aplicacao transdermicacontendo gestodeno
ATE232720T1 (de)	2003-03-15	Adjuvans für impfstoff
ATE333867T1 (de)	2006-08-15	Emulgierte arzneistoffabgabesysteme
DE59604603D1 (de)	2000-04-13	Arzneiform zur abgabe von wirkstoffen an wunden
BR9504781A (pt)	1996-10-15	Composição cosmética ou dematológica processo de preparação de uma composição e emulsão do tipo óleo em agua
FI971776A0 (fi)	1997-04-25	Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
BR9510452A (pt)	1998-05-19	Composição farmacêutica e aquosa estéril para a administração parenteral processos para limitar o potencial de crescimento microbiano em composição farmacêutica estéril para a administração parenteral para produzir anestesia em um animal de sangue quente e para aperfeiçoar o tempo de administração e/ou o tempo entre as trocas de conjuntos
ES2081488T3 (es)	1996-03-16	Uso de fosfolipido en la fabricacion de un medicamento topico para modificar los niveles de colesterol serico.
FI935851A0 (fi)	1993-12-23	Antiallergisk sammansaettning foer oftalmiskt eller nasalt bruk
ES2136315T3 (es)	1999-11-16	Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones.
DE69121561D1 (de)	1996-09-26	Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
BR9809492A (pt)	2000-06-20	Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
ATE223205T1 (de)	2002-09-15	Verfahren zur herstellung von liposomen, die hydrophobische artzneistoffe enthalten
BR0211008A (pt)	2004-10-26	Combinação de ingrediente ativo, uso de uma combinação de ingrediente ativo e método para a terapia farmacológia de uma substância que causa dependência ou que seja intoxicante
ES2090712T3 (es)	1996-10-16	Medicamento agudo que contiene ibuprofeno y su uso.
ES2090703T3 (es)	1996-10-16	Medicamento agudo que contiene flurbiprofeno y su empleo.
ATE132758T1 (de)	1996-01-15	Anwendung von dispersionen von magneto-ionischen partikeln in mri-kontrast-mitteln
ATE221919T1 (de)	2002-08-15	In flüssiger form stabiler thiolaktivator
ATE374594T1 (de)	2007-10-15	Zusammensetzung in form einer öl-in-wasser emulsion und deren kosmetische verwendungen
BR0213434A (pt)	2004-11-09	Método para evitar demência em um paciente, e, uso de rosuvastatina ou seu sal farmaceuticamente aceitável
ATE131031T1 (de)	1995-12-15	Zubereitung zur topischen anwendung.
GB9902527D0 (en)	1999-03-24	Compositions
MX9801902A (es)	1998-11-29	Composicion dermatologica antiseptica y procedimiento para su fabricacion.

Legal Events

Date	Code	Title	Description
2002-11-15	UEP	Publication of translation of european patent specification
2007-09-15	REN	Ceased due to non-payment of the annual fee